Oskira-1: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To Methotrexate
Author(s):
Weinblatt, M.; Genovese, M.C.; Ho, M.; Hollis, S.; Rosiak-Jedrychowicz, K.; Kavanaugh, A.; Millson, D.; Leon, G.; Wang, M.; Heijde, D. van der
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-10-31
Language
English
Is part of
Arthritis and Rheumatism (2013), Vol. 65, p. S763-S764
